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Calcium is a key regulator of many physiological processes that are perturbed in cancer, such as migration, proliferation and 
apoptosis. The proteins STIM and Orai mediate store-operated calcium entry (SOCE), the main pathway for calcium entry in 
non-excitable cells. Changes in the expression and function of STIM and Orai have been found in a range of cancer types and 
thus implicated in disease progression. Here we discuss the role of STIM, Orai and the SOCE pathway in the progression of 
melanoma and explore how the heterogeneous nature of melanoma may explain the lack of consensus in the field regarding the 
role of SOCE in the progression of this disease. 
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Ultraviolet (UV) radiation can lead to DNA damage by 
causing adjacent thymine base pairs to form pyrimidine 
dimers (Goodsell, 2001). To protect against such damage, 
melanocyte cells, located in the basal layer of the epidermis, 
produce the UV absorbing pigment melanin for export to 
keratinocytes, the predominant cell of the skin (Raposo and 
Marks, 2007). Fair-skinned individuals, however, with low 
levels of skin melanin, are particularly susceptible to 
UV-induced DNA damage, the primary risk factor in de-
veloping skin cell cancers. Malignant melanoma is one such 
cancer, originating from the melanocyte cell lineage 
(Schadendorf et al., 2015). While in the radial growth phase 
in the skin, malignant melanoma is easily treatable by sur-
gical excision of the cutaneous lesions. However, once 
melanoma enters the vertical growth phase, the cells infil-
trate the dermis and metastasize, 5-year survival rate falls to  
15% (http://www.cancer.org/research/cancerfactsfigures/ 
cancerfactsfigures/cancer-facts-figures-2013), making this a 
particularly deadly disease. Understanding how and why 
melanoma transitions to a metastatic state is therefore key to 
preventing disease progression and ultimately improving 
patient prognosis. 
THE STORE-OPERATED CALCIUM ENTRY 
(SOCE) PATHWAY 
Calcium (Ca2+), a ubiquitous signaling ion and intracellular 
second messenger, is critical to a plethora of physiological 
processes, many of which are perturbed in cancer such as 
cell migration, proliferation and apoptosis (Berridge and 
Irvine, 1984). The primary store of intracellular Ca2+ is the 
endoplasmic reticulum (ER) with a luminal Ca2+ concentra-
tion of ~100 µmol L1, approximately 1000-fold higher than 
the cytoplasm. Upon agonist activation of phospholipase C 
(PLC)-coupled cell surface receptors (such as Gq/11 coupled 
G-protein coupled receptors), phosphatidylinositol 
4,5-bisphosphate (PIP2) is hydrolyzed to diacyl glycerol 
(DAG) and inositol 1,4,5-trisphosphate (InsP3), the latter of 
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which acts upon ER-resident InsP3 receptors to release Ca
2+ 
from the ER lumen (Figure 1). Ca2+ signals are finitely con-
trolled by the amplitude, location, duration and frequency of 
Ca2+ release, the so called “Ca2+ signature” (Berridge et al., 
2000) that governs downstream cellular response. Ca2+ is 
then extruded from the cell via the plasma membrane Ca2+ 
ATPase (PMCA) (Carafoli, 1991). As Ca2+ is released, its 
concentration in the ER lumen decreases leading to Ca2+ 
dissociation from the luminal EF-hands of ER-resident 
STIM proteins (Soboloff et al., 2012). Loss of Ca2+ binding 
leads to a conformational change in STIM, causing it to 
oligomerize and cluster at ER-plasma membrane (PM) 
junctions where the carboxy-terminus of the protein extends 
to interact with and activate PM Orai channels, gating Ca2+ 
influx. This process is termed store-operated Ca2+ entry 
(SOCE). There are two isoforms of STIM proteins and three 
Orai family members with STIM1 and Orai1 being the most 
extensively studied of these. Ca2+ is then taken up into the 
ER via the sarco/endoplasmic reticulum ATPase (SERCA) 
pump, refilling the intracellular store. Multiple other pro-
teins are also integral to regulating Ca2+ entry and signaling, 
TRP channels, activated by a diverse array of stimulants 
(Venkatachalam and Montell, 2007), can mediate Ca2+ entry 
into a cell, independent of ER Ca2+ content, while Ca2+ is 
also pumped into mitochondria, the Golgi and endo- 
lysosomes within the cell (Xu et al., 2015). 
A ROLE FOR SOCE IN CANCER 
PROGRESSION 
STIM1- and Orai1-generated Ca2+ signals have been impli-
cated in cell migration and focal adhesion turnover in both 
normal cell function and disease models (Pan and Ma, 
2015). Indeed, metastasis involves a loss of cell adhesion 
from the primary tumor, cell migration through extracellular 
matrix, adhesion to a secondary site then cell proliferation. 
Orai1 was shown to regulate focal adhesion formation at the 
leading edge of migrating HEK293 cells, while STIM1, 
perhaps independently from the process of SOCE, contrib-
uted to disassembly of focal adhesions at the rear of cells 
(Schafer et al., 2012). Broadly, knockdown of either of the 
primary SOCE components leads to a decrease in cell mi-
gration velocity. Indeed, migrating endothelial cells stimu-
lated by chemoattractants, exhibit a front-to-rear Ca2+ gra-
dient, with STIM/Orai-dependent Ca2+ pulses at the leading 
edge of the cell promoting the focal adhesion formation at 
the site of stimulation, thus driving directional movement 
(Tsai et al. 2014). STIM1 and Orai1 have also been demon-
strated to play a role in cell migration and invasion in nu-
merous cancers. Knockdown of either protein or pharmaco-
logical inhibition of SOCE was shown to increase focal 
adhesions in human MDA-MB-231 breast cancer cells and 
thus decrease tumor metastasis in a mouse model of breast  
 
 
Figure 1  Wnt5a signals to inactivate Orai1. (1) Upon activation of phospholipase C (PLC)-coupled plasma membrane receptors (such as a Gq/11 coupled 
GPCR), phosphatidylinositol 4,5-bisphosphate (PIP2) is hydrolyzed to diacyl glycerol (DAG) and inositol 1,4,5-trisphosphate (InsP3). (2) InsP3 binds InsP3 
receptors leading to Ca2+ release from the ER and (3) extrusion from the cell by the plasma membrane ATPase (PMCA). (4) As luminal ER Ca2+ concentra-
tion falls, Ca2+ dissociates from the EF-hands of STIM1 leading it to oligomerize and cluster at ER-PM junctions where it can gate Orai1 channels and facil-
itate store-operated calcium entry (SOCE) and (5) reuptake of Ca2+ into the ER via the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump. In mela-
noma cells, (6) Wnt5a activates the co-receptors Frizzled (Fzd) and receptor tyrosine kinase-like orphan receptor 2 (ROR2), part of the non-canonical Wnt 
signaling pathway, leading to the generation of DAG and InsP3. DAG activates PKC, which is known to phosphorylate Orai1 (7), leading to channel inacti-
vation. Invasive melanoma cells with high levels of Wnt5a therefore have attenuated SOCE.  
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cancer progression (Yang et al., 2009). Similarly, high lev-
els of STIM1 were positively correlated to tumor invasion 
and metastasis in colorectal cancer, where endogenous lev-
els were found to be upregulated in diseased tissue (Wang et 
al., 2015). STIM1 was found to drive migration by promo- 
tion of COX-2 expression and subsequent production of 
prostaglandin E2 in colorectal cancer cells. In brain tumor 
glioblastoma multiforme (GBM) cells, Orai1 levels were 
found to be higher than in human primary astrocytes, with 
an associated increase in the magnitude of SOCE in these 
cells (Motiani et al., 2013). Furthermore, knockdown of 
STIM1 and Orai1 led to a decrease in the ability of GBM 
cells to invade but with little effect on proliferation. Like-
wise, STIM1 was expressed at higher levels in gastric can-
cer cells than normal tissue, and again STIM1 knockdown 
inhibited cell migration and invasion (Xu et al., 2016). 
Therefore, in a variety of cancer types, both STIM1 and 
Orai1 were found to be upregulated and positively correlat-
ed to metastasis. 
Conversely, in A459 lung cancer cells, overexpression of 
Orai1 or the use of pharmacological SOCE antagonists in-
hibited EGF-mediated cell proliferation by placing cells in 
G0/G1 cell cycle arrest (Hou et al., 2011). In human pros-
tate cancer cells, downregulation of Orai1 and decreased 
SOCE was correlated to an apoptosis-resistant phenotype, 
suggesting that loss of SOCE could contribute to the uncon-
trolled proliferation of cancer cells (Flourakis et al., 2010). 
SOCE may therefore play differing roles in cancer progres-
sion depending on cell type or be locally altered in ways 
that promote migration and metastasis through control of 
focal adhesion turnover. 
WNT5A-MEDIATED ORAI1 INHIBITION IS 
CORRELATED TO MELANOMA 
INVASIVENESS 
We recently found that in patient-derived melanoma cell 
lines, those that were categorized as high in levels of Wnt5a 
and thus of an invasive phenotype, had dramatically less 
SOCE than non-invasive melanoma lines (Hooper et al., 
2015). Wnt5a binds to the G-protein coupled receptor Fzd 
and the tyrosine kinase receptor ROR2 to mediate signaling. 
In melanoma, as well as gastric cancer and pancreatic ade-
nocarcinoma, the non-canonical WNT pathway is engaged, 
independent of -catenin, to activate downstream effectors 
such as PKC, Akt and Jnk and promote metastasis (Webster 
and Weeraratna, 2013; Zhu et al., 2014) (Figure 2). Con-
versely, in breast, thyroid, colon and hematopoietic cancers, 
increased Wnt5a expression can decrease metastasis. In 
these cancers, Wnt5a still binds to Fzd and ROR2, but re-
ceptor engagement instead inhibits the canonical Wnt- 
signaling pathway to promote -catenin degradation and 
prevents the transcription of genes involved in tumor pro-
gression (Figure 2) (Zhu et al., 2014). 
We observed that knocking down Wnt5a in invasive 
melanoma cell lines increased SOCE, while conversely 
overexpression of Wnt5a in non-invasive cells diminished 
SOCE to levels recorded in invasive cells (Hooper et al., 
2015). This demonstrated a direct link between Wnt5a lev- 
 
 
Figure 2  The canonical and non-canonical Wnt pathways have differing effects in cancer. A, Wnt1/3 binds the G-protein coupled receptor Fzd and the 
tyrosine kinase receptors LRP5/6 to initiate signaling through the canonical signaling pathway. The resulting signaling complex promotes β-catenin translo-
cation to the nucleus and thus drives the radial growth phase of melanoma, whereby cells differentiate and proliferate on the dermis. B, An increase in Wnt5a 
activates the non-canonical Wnt signaling pathway through Fzd and the tyrosine kinase ROR2. Downstream effectors such as Arf6, Akt, Jnk and PKC drive 
a transition to the vertical growth phase, whereby melanoma invade through the dermis and metastasize. C, Conversely, in breast cancer cells, Wnt5a signal-
ing though the non-canonical pathway activates CAMKII to facilitate -catenin degradation, preventing the transcription of genes that promote metastasis 
and invasion. 
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els and SOCE in melanoma cells. The lack of SOCE in in-
vasive cells was not however, due to any loss of SOCE 
components since expression of STIM and Orai proteins 
showed no correlation with invasiveness. Further, no de-
fects in the localization or ability of these proteins to inter-
act was observed, as evidenced by FRET studies. Finally, 
overexpression of STIM1 and Orai1 failed to restore SOCE 
in any of the Wnt5a-expressing invasive melanoma cell 
lines examined (Hooper et al., 2015).  
It is known that when Wnt5a is upregulated, protein ki-
nase C (PKC) activity is elevated (Dissanayake and Weer- 
aratna, 2008). We found this elevated PKC activity was 
apparently responsible for the reduction in SOCE due to 
Orai1 phosphorylation, a process previously demonstrated 
to negatively regulate the channel in vitro (Kawasaki et al., 
2010). Hence, use of the PKC inhibitor gö6983 or expres-
sion of an Orai1 protein insensitive to PKC-phosphorylation 
(Orai1S27/30A) led to SOCE restoration in invasive cells, but 
had no effect (relative to Orai1WT for the latter) in 
non-invasive cells. Furthermore, both Wnt5a knockdown or 
PKC inhibition decreased the invasive potential of melano-
ma in vitro. Therefore an inverse relationship exists be-
tween Wnt5a levels/PKC activity and SOCE via Orai1 
phosphorylation (Figure 1). It remains to be elucidated 
whether the loss of SOCE itself promotes invasion by alter-
ing Ca2+ dynamics or whether loss of SOCE is a byproduct 
of cells changing to an invasive phenotype.  
DIFFERING ROLES OF SOCE IN MELANOMA 
PROGRESSION 
Interestingly, work by other groups studying melanoma cell 
lines with different characteristics has tended to support an 
alternative model in which melanoma invasiveness is posi-
tively correlated with SOCE, consistent with findings in 
other cancer types (Vashisht et al., 2015). One of the first 
reports on the role of STIM and Orai in melanoma exam-
ined mouse B16BL6 cells, where SOCE was shown to be 
enhanced in malignant cells with downstream activation of 
protein kinase B/Akt (Feldman et al., 2010). The authors 
found that while there were no differences in STIM1 or 
Orai1 expression between malignant and non-malignant 
cells, Orai1 likely remained open longer to increase influx 
and this elevated Ca2+ was buffered by the mitochondria. 
Notably, inhibiting mitochondrial Ca2+ uptake could de-
crease SOCE, suggesting a level of cross-talk between the 
two processes, with loss of SOCE leading to loss of PKB 
activation, ablated cell growth and increased cell suscepti-
bility to apoptosis.  
More recently, Stanisz et al. reported SOCE in both pri-
mary (SK-MEL-28) and metastatic (SK-MEL-5, WM3734) 
melanoma cells, although either pharmacological SOCE 
inhibition or knockdown of Orai1 and STIM2 resulted in 
faster growth, linked to malignancy (Stanisz et al., 2014). 
However, due to the commonly observed inverse relation-
ship between proliferation and invasiveness (Liotta and 
Stetler-Stevenson, 1991), this fast growth leads to decreased 
invasive potential not dissimilar from the findings of our 
study (Hooper et al., 2015). In contrast, another group found 
that SOCE was actually enhanced in metastatic melanoma 
compared to non-metastatic primary melanoma cells and 
melanocytes (Umemura et al., 2014). Notably, unlike the 
melanoma lines characterized in (Hooper et al., 2015; 
Feldman et al., 2010; Stanisz et al., 2014), STIM1 and 
Orai1 were found to be highly expressed in melanoma, but 
no expression of their homologs was observed (Hooper et 
al., 2015; Feldman et al., 2010; Stanisz et al., 2014). 
Umemura et al. further found that suppression of SOCE by 
knockdown of STIM1 or Orai1 or use of the pharmacologi-
cal SOCE inhibitor YM58483, drastically decreased cell 
migration in a Boyden chamber assay and decreased lung 
metastatic colonization post tail-vein injection (Umemura et 
al., 2014). These SOCE-mediated effects were attributed to 
activation of the extracellular-signal-regulated kinase 
(ERK) pathway and could be blocked by inhibitors of cal-
modulin kinase II (CaMKII) or Raf-1.  
A role for STIM1 and Orai1-mediated Ca2+ oscillations 
was further demonstrated in the context of cell invado-
podium assembly and extracellular matrix (ECM) degrada-
tion in models of melanoma metastasis (Sun et al., 2014). 
Ca2+ oscillations were also shown to be necessary for Src 
activation in melanoma cells, which recruits cortactin and 
the adaptor protein TKS5 to promote actin assembly and the 
formation of invadopodia structures (Sun et al., 2014). Fur-
ther, Orai1-mediated signaling was found to be integral for 
trafficking MT1-matrix metalloproteinase (MMP) to the 
plasma membrane, where it facilities ECM degradation and 
promotes cell invasion. STIM1 and Orai1-mediated Ca2+ 
signals were thus shown to be implicated in processes nec-
essary to metastasis. Indeed, knockdown of STIM1 inhibit-
ed melanoma lung metastasis in a mouse xenograft model 
(Sun et al., 2014). 
THE HETEROGENEITY OF MELANOMA: 
IMPLICATIONS FOR Ca2+ SIGNALING  
Melanoma is a highly heterogeneous disease, driven by a 
range of oncogenic proteins, which hampers effective 
treatment upon metastasis (Schadendorf et al., 2015). Our 
work focused on cells that were characterized as invasive 
based on Wnt5a expression and these cells showed greatly 
attenuated SOCE (Hooper et al., 2015). It is likely that other 
groups utilized invasive cells that had no differences in 
Wnt5a, indeed Wnt5a-positive invasive cells may represent 
a subset of metastatic melanomas and may require drasti-
cally different treatment strategies from invasive cells that 
aren’t driven by Wnt5a. In one study, Wnt5a protein and 
transcript levels were found to be upregulated in cell lines 
and patient samples that were resistant to BRAF-inhibitor 
(Anastas et al., 2014). Indeed, based on the publications 
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discussed here, it could be envisaged that SOCE inhibition 
and SOCE enhancement may both represent valid treatment 
strategies tailored to different melanoma types, with the 
goal of “normalizing” SOCE in invasive, metastatic cells. 
Also it should be noted that, although we observe greatly 
attenuated SOCE in invasive cells compared to non- 
invasive, these cells still have some limited Ca2+ entry. 
Stanisz et al. show SOCE in SK-MEL-5 cells that has a 
peak amplitude similar to that of the Tg-induced ER Ca2+ 
blockade, while the SOCE observed in their WM3734 cells 
is almost 4-fold greater compared to the Tg-response (using 
control siRNA) (Stanisz et al., 2014), suggesting some  
dynamic range.  
It is, perhaps, not surprising that melanoma cells with 
different genetic backgrounds exhibit differential depend-
ence on SOCE, however, the interdependence of these phe-
nomena has not been directly assessed. Further, the extent 
to which SOCE affects the invasive phenotype in these dif-
ferent genetic backgrounds remains unclear. Hence, a com-
prehensive screen of available melanoma cell lines and pri-
mary melanomas may provide new insight into both the 
regulation of SOCE in melanoma and how SOCE relates to 
the invasive features of this disease. 
The expression and function of other Ca2+-permeable ion 
channels may also influence the dependence of melanoma 
on SOCE. Hence, transient receptor potential melastatin 1 
(TRPM1), a member of the TRP super-family of ion chan-
nels, is expressed in melanocytes, where it is integral to 
melanin synthesis. Interestingly, loss of TRPM1 has been 
described as a marker of melanoma aggressiveness and tu-
mor thickness (Miller et al., 2004) although how this affects 
Ca2+ homeostasis has not been investigated, nor has the in-
fluence of TRPM1 on SOCE in invasive melanoma been 
determined. Another member of the TRPM family, TRPM8, 
was shown to be functionally expressed in melanoma cells 
with sustained Ca2+ influx mediated by the channel agonist 
menthol leading to decreased viability of cells (Yamamura 
et al., 2008), although TRPM8 is also involved in normal 
melanocyte physiology so the extent to which this phenom-
enon is specific to melanoma is not clear.  
Given the intimate relationship between Ca2+ signals and 
migration, investigations into how SOCE and other Ca2+ 
signaling pathways are altered in a range of melanoma cells 
may provide an invaluable guide for future therapies target-
ing Ca2+ homeostasis as a way to modulate melanoma me-
tastasis. 
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